IP Library Granted Patent US 7,179,634
Granted Patent B2
US 7,179,634 · App. 09/834,271 · Granted Feb 20, 2007

Methods for producing a polypeptide in a

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,179,634
App. No.
09/834,271
Granted
Feb 20, 2007
Kind
B2
Abstract

The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a Bacillus host cell in a medium conducive for the production of the polypeptide, wherein the Bacillus cell comprises a nucleic acid construct comprising (i) a tandem promoter in which each promoter sequence of the tandem promoter is operably linked to a single copy of a nucleic acid sequence encoding the polypeptide and alternatively also (ii) an mRNA processing/stabilizing sequence located downstream of the tandem promoter and upstream of the nucleic acid sequence encoding the polypeptide; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to methods for producing a polypeptide, comprising: (a) cultivating a Bacillus host cell in a medium conducive for the production of the polypeptide, wherein the Bacillus cell comprises a nucleic acid construct comprising (i) a “consensus” promoter having the sequence TTGACA for the “−35” region and TATAAT for the “−10” region operably linked to a single copy of a nucleic acid sequence encoding the polypeptide and (ii) an mRNA processing/stabilizing sequence located downstream of the “consensus” promoter and upstream of the nucleic acid sequence encoding the polypeptide; and (b) isolating the polypeptide from the cultivation medium.

Claims (13)

1. A Bacillus cell comprising a nucleic acid construct which comprises (a) a “consensus” promoter of a Bacillus amyloliquefaciens alpha-amylase gene (amyQ) having the sequence TTGACA for the “−35” region and TATAAT for the “−10” region and having the nucleic acid sequence of SEQ ID NO:26 or SEQ ID NO:27 further operably linked to a single copy of a nucleic acid sequence encoding a polypeptide, and (b) a cryIIIA mRNA processing/stabilizing sequence located downstream of the “consensus” promoter and upstream of the nucleic acid sequence encoding the polypeptide, wherein the mRNA processing/stabilizing sequence increases expression of the nucleic acid sequence encoding the polypeptide.

2. The Bacillus cell of claim 1 , which contains one or more copies of the nucleic acid construct.

3. The Bacillus cell of claim 1 , which contains one copy of the nucleic acid construct.

4. The Bacillus cell of claim 1 , wherein the nucleic acid construct further comprises a selectable marker gene.

5. The Bacillus cell of claim 1 , which contains no selectable marker gene.

6. The Bacillus cell of claim 1 , wherein the nucleic acid sequence encodes a polypeptide heterologous to the Bacillus cell.

7. The Bacillus cell of claim 1 , wherein the polypeptide is a hormone, enzyme, receptor, antibody, or reporter.

8. The Bacillus cell of claim 7 , wherein the enzyme is an oxidoreductase, transferase, hydrolase, lyase, isomerase, or ligase.

9. The Bacillus cell of claim 7 , wherein the enzyme is an aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, invertase, laccase, lipase, mannosidase, mutanase, oxidase, a pectinolytic enzyme, peroxidase, phytase, polyphenoloxidase, proteolytic enzyme, ribonuclease, transglutaminase, or xylanase.

10. The Bacillus cell of claim 1 , wherein the nucleic acid sequence is contained in the chromosome of the Bacillus cell.

11. The Bacillus cell of claim 1 , wherein the nucleic acid sequence is contained on an extrachromosomal element.

12. The Bacillus cell of claim 1 , which is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausli, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis , or Bacillus thuringiensis cell.

13. The Bacillus cell of claim 1 , which is a Bacillus subtilis cell.

Assignments (2)
CHANGE OF NAME Recorded Sep 1, 2005
From: NOVOZYMES, INC.
To: NOVOZYMES, INC.
Reel/Frame 016937/0522 →
CHANGE OF NAME Recorded Oct 9, 2001
From: NOVO NORDISK BIOTECH, INC.
To: NOVOZYMES BIOTECH, INC.
Reel/Frame 012232/0819 →